Authors
Ken Ogura, Kentaro Kamiya, Nobuaki Hamazaki, Emi Maekawa, Chiharu Noda, Momoko Ikeda, Koshi Suzuki, Honoka Mibe, Eishin Konishi, Kohei Matsuda, Kaoru Sato, Takashi Miki, Keisuke Kida, Norio Suzuki, Takeo Fujino, Shoei Yamamoto, Takenori Ikoma, Yusuke Mizuno, Ichiro Matsumoto, Shinjiro Miyazaki, Taisuke Nakade, Yuya Matsue
Published in
JACC. Advances. Volume 5. Issue 8. Pages 103008. Jul 15, 2026. Epub Jul 15, 2026.
Abstract
The prognostic value of cardiopulmonary exercise testing (CPET) parameters, particularly peak oxygen consumption (VO2) and minute ventilation/carbon dioxide production (VE/VCO2) slope, in patients aged ≥80 years with heart failure (HF) remains unclear.
The study evaluated the age-stratified prognostic value of CPET parameters for adverse outcomes in patients with HF.
In this retrospective multicenter cohort study, we included 830 patients with HF who underwent CPET. The primary outcome was a composite of all-cause death or HF hospitalization within 3 years. CPET parameters were examined in 3 age groups: 20 to 64, 65 to 79, and ≥80 years.
During a median follow-up time of 2.8 years, 176/830 patients experienced adverse outcomes. Peak VO2 was associated with adverse outcomes in patients 65 years or older (≥80 years: HR: 0.72; 95% CI: 0.62-0.85; 65-79 years: HR: 0.90; 95% CI: 0.84-0.96). VE/VCO2 slope was consistently associated across age groups (P < 0.05 for all). The area under the curves (95% CI) of peak VO2 tended to increase with age (20-64 years: 0.61 [0.53-0.69], 65-79 years: 0.74 [0.67-0.81], ≥80 years: 0.81 [0.70-0.91]), whereas VE/VCO2 slope was comparable across age groups (20-64 years: 0.64 [0.56-0.72], 65-79 years: 0.68 [0.60-0.76], ≥80 years: 0.68 [0.55-0.81]).
Although CPET parameters were associated with adverse outcomes across age groups, the prognostic contribution of peak VO2 was most pronounced in older patients with HF, highlighting the importance of CPET-based risk stratification in this population.
PMID:
42456265
Bibliographic data and abstract were imported from PubMed on 16 Jul 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 1
- Comments 0